Bipolar disorder: Involvement of signaling cascades and AMPA receptor trafficking at synapses

Neuron Glia Biology

Volumn 1, Issue 3, 2004, Pages 231-243

  Du, Jing ^a   Quiroz, Jorge ^b   Yuan, Peixiong ^b   Zarate, Car OS ^b   Manji, Husseini Y ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NONE

Author keywords

antidepressant; bipolar disorder; glutamatergic system; Lithium; valproate

Indexed keywords

EID: 85009890734     PISSN: 1740925X     EISSN: 17410533     Source Type: Journal    
DOI: 10.1017/S1740925X05000098     Document Type: Article

References (57)

1. Antonny B., Schekman R. 2001 ER export: public transportation by the COPII coach. Current Opinion in Cell Biology 13 438-443
2. Backstrom P. and Hyytia P. (NGJI2003) Attenuation of cocaine-seeking behaviour by the AMPA/kainate receptor antagonist CNQX in rats. Psychopharmacology (Berl) 166, 69–76.
3. Beaulieu J.M., Sotnikova T.D., Yao W.D., Kockeritz L., Woodgett J.R., Gainetdinov R.R. et al. (2004) Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proceedings of the National Academy of Sciences of the U.S.A. 101, 5099–5104.
4. Bebchuk J.M., Arfken C.L., Dolan-Manji S., Murphy J., Hasanat K. and Manji H.K. (2000) A preliminary investigation of a protein kinase C inhibitor in the treatment of acute mania. Archives of General Psychiatry 57,95-97.
5. Benavides J., Camelin J.C., Mitrani N., Flamand F., Uzan A., Legrand J.J. et al. (1985) 2-Amino-6-trifluoromethoxy benzothiazole, Derkach V., Barria A. and Soderling T.R. (1999) Ca2+/calmodulin-kinase II enhances channel conductance of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate type glutamate receptors. Proceedings of the National Academy of Sciences of the U.S.A. 96,3269-3274.
6. Dixon J.F. and Hokin L.E. (1998) Lithium acutely inhibits and chronically up-regulates and stabilizes glutamate uptake by presynaptic nerve endings in mouse cerebral cortex. Proceedings of the National Academy of Sciences of the U.S.A. 95, 8363–8368.
7. Drevets W.C. (2001) Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Current Opinion in Neurobiology 11, 240–249.
8. Du J., Gould T. and Manji H.K. (2003) Neurotrophic signaling in mood disorders. In Finkel T, Gutkind J.S. (eds) Signal Transduction and Human Disease. John Wiley and Sons, pp. 411–446.
9. Du J., Gray N.A., Falke C.A., Chen W., Yuan P., Szabo S.T. et al. (2004a) Modulation of synaptic plasticity by antimanic agents: the role of AMPA glutamate receptor subunit 1 synaptic expression. Journal of Neuroscience 24, 6578–6589.
10. Du J., Szabo S.T., Gray N.A. and Manji H.K. (2004b) Focus on CaMKII: a molecular switch in the pathophysiology and treatment of mood and anxiety disorders. International Journal of Neuropsychopharmacology 7, 243–248.
11. Du J., Gray N.A., Gould T.D., Zerate C. and Manji H.K. (2004c) Regulation of cellular plasticity and resilience by mood stabilizers: the role of AMPA receptor trafficking. Dialogues in Clinical Neuroscience 5, 143–155.
12. Ehlers M.D. (2000) Reinsertion or degradation of AMPA receptors determined by activity-dependent endocytic sorting. Neuron 28, 511–525.
13. Einat H., Yuan P., Gould T.D., Li J., Du J., Zhang L. et al. (2003) The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. Journal of Neuroscience 23, 7311–7316.
14. Emamghoreishi M., Schlichter L., Li P.P., Parikh S., Sen J., Kamble A. et al. (1997) High intracellular calcium concentrations in transformed lymphoblasts from subjects with bipolar I disorder. American Journal of Psychiatry 154, 976–982.
15. Fink C.C. and Meyer T. (2002) Molecular mechanisms of CaMKII activation in neuronal plasticity. Current Opinion in Neurobiology 12, 293–299.
16. Friedman E., Hoau Yan W., Levinson D., Connell T.A. and Singh H. (1993) Altered platelet protein kinase C activity in bipolar affective disorder, aanic episode. Biological Psychiatry 33, 520–525.
17. Genoux D., Haditsch U., Knobloch M., Michalon A., Storm D. and Mansuy I.M. (2002) Protein phosphatase 1 is a molecular constraint on learning and memory. Nature 418, 970–975.
18. Goodwin F.K. and Jamison K.R. (1990) Manic-Depressive Illness. Oxford University Press.
19. Gould T.D., Chen G. and Manji H.K. (2004a) In Vivo Evidence in the Brain for Lithium Inhibition of Glycogen Synthase Kinase-3. Neuropsychopharmacology 29,32-38.
20. Gould T.D. and Manji H.K. (2002) Signaling networks in the pathophysi-ology and treatment of mood disorders. Journal of Psychosomatic Research 53, 687–697.
21. Gould T.D., Quiroz J.A., Singh J., Zarate C.A. and Manji H.K. (2004b) Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers. Molecular Psychiatry 9, 734–755.
22. Gray N., Du J., Falke C., Yuan P. and Manji H. (2003) Lithium regulates total and synaptic expression of the AMPA Glutamate Receptor GluR2 in vitro and in vivo. Annals of the New York Academy of Science 1003, 402–404
23. Liao D., Scannevin R.H. and Huganir R. (2001) Activation of silent synapses by rapid activity-dependent synaptic recruitment of AMPA receptors. Journal of Neuroscience 21, 6008–6017.
24. Lucas F.R., Goold R.G., Gordon-Weeks P.R. and Salinas P.C. (1998) Inhibition of GSK-3beta leading to the loss of phosphorylated MAP-iB is an early event in axonal remodelling induced by WNT-7a or lithium. Journal of Cell Science 111,1351-1361.
25. Lucas F.R. and Salinas P.C. (1997) WNT-7a induces axonal remodeling and increases synapsin I levels in cerebellar neurons. Developmental Biology 192,31-44.
26. Malenka R.C. and Nicoll R.A. (1999) Long-term potentiation-a decade of progress? Science 285,1870-1874.
27. Mangiavacchi S. and Wolf M.E. (2004) Di dopamine receptor stimulation increases the rate of AMPA receptor insertion onto the surface of cultured nucleus accumbens neurons through a pathway dependent on protein kinase A. Journal of Neurochemistry 88,1261-1271.
28. Manji H.K. (1992) G proteins: implications for psychiatry. American Journal of Psychiatry 149,746-760.
29. Manji H.K., Chen G., Shimon H., Hsiao J.K., Potter W.Z. and Belmaker R.H. (1995) Guanine nucleotide-binding proteins in bipolar affective disorder. Effects of long-term lithium treatment. Archives of General Psychiatry 52,135-144.
30. Manji H.K., Drevets W.C. and Charney D.S. (2001) The cellular neurobiology of depression. Nature Medicine 7, 541–547.
31. Manji H.K. and Lenox R.H. (1999) Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness. Biological Psychiatry 46,1328-1351.
32. Manji H.K. and Lenox R.H. (2000a) The nature of bipolar disorder. Journal of Clinical Psychiatry 61 Supp 13, 42–57.
33. Manji H.K. and Lenox R.H. (2000b) Signaling: cellular insights into the pathophysiology of bipolar disorder. Biological Psychiatry 48, 518–530.
34. Martinez-Turrillas R., Frechilla D. and Del Rio J. (2002) Chronic antide-pressant treatment increases the membrane expression of AMPA receptors in rat hippocampus. Neuropharmacology 43,1230-1237.
35. Matsuda S., Launey T., Mikawa S. and Hirai H. (2000) Disruption of AMPA receptor GluR2 clusters following long-term depression induction in cerebellar Purkinje neurons. EMBO Journal 19, 2765–2774.
36. Mead A.N. and Stephens D.N. (1992) AMPA-receptors are involved in the expression of amphetamine-induced behavioural sensitisation, but not in the expression of amphetamine-induced conditioned activity in mice. Neuropharmacology 37,1131-1138.
37. Mitchell P.B., Manji H.K., Chen G., Jolkovsky L., Smith-Jackson E., Denicoff K. et al. (1997) High levels of Gs alpha in platelets of euthymic patients with bipolar affective disorder. American Journal of Psychiatry 154, 218–223.
38. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J. and Monteggia L.M. (2002a) Neurobiology of depression. Neuron 34,13-25.
39. Nestler E.J., Gould E., Manji H., Buncan M., Duman R.S., Greshenfeld H.K. et al. (2002b) Preclinical models: status of basic research in depression. Biological Psychiatry 52, 503–528.
40. Newton A.C. (1995) Protein kinase C: structure, function, and regulation. Journal of Biological Chemistry 270, 28495–28498
41. Wang H.Y. and Friedman E. (1996) Enhanced protein kinase C activity and translocation in bipolar affective disorder brains. Biological Psychiatry 40,568-575.
42. Wang H.Y. and Friedman E. (1999) Effects of lithium on receptor-mediated activation of G proteins in rat brain cortical membranes. Neuropharmacology 38,403-414.
43. Wang S.J., Huang C.C., Hsu K.S., Tsai J.J. and Gean P.W. (1996) Presynaptic inhibition of excitatory neurotransmission by lamotrigine in the rat amygdalar neurons. Synapse 24, 248–255.
44. Warsh J., Young L. and Li P. (2000a) Guanine nucleotide binding (G) proteindisturbances. In Belmaker, R. (ed.) Bipolar Affective Disorder in Bipolar Medications: Mechanisms of Action. American Psychiatric Press, pp. 299–329.
45. Warsh J.J., Young L.T. and Li P.P. (2000b) Guanine nucleotide binding (G) protein disturbances. In Belmaker, R. (ed.) Bipolar Affective Disor-der in Bipolar Medications: Mechanisms of Action. American Psychiatric Press, pp. 299–329.
46. Weng G., Bhalla U.S. and Iyengar R. (1999) Complexity in biological signaling systems. Science 284, 92–96.
47. Wo Z.G., Bian Z.C. and Oswald R.E. (1995) Asn-265 of frog kainate binding protein is a functional glycosylation site: implications for the transmembrane topology of glutamate receptors. FEBS Letters 368, 230–234.
48. Wong C.S., Cherng C.H., Luk H.N., Ho S.T. and Tung C.S. (1996) Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors. European Journal of Pharmacology 297,27-33.
49. Xia J., Chung H.J., Wihler C., Huganir R.L. and Linden D.J. (2000) Cerebellar long-term depression requires PKC-regulated interactions between GIUR2/3 and PDZ domain-containing proteins. Neuron 28, 499–510.
50. Yoon I.S., Li P.P., Siu K.P., Kennedy J.L., Cooke R.G., Parikh S.V. et al. (2001a) Altered IMPA2 gene expression and calcium homeostastis in bipolar disorder. Molecular Psychiatry 6, 678–683.
51. Yoon I.S., Li P.P., Siu K.P., Kennedy Macciardi F., Cooke R.G. et al (2001b) Altered TRPC7 gene expression in bipolar-i disorder. Biological Psychiatry 50, 620–626.
52. Young L.T. (2002) Neuroprotective effects of antidepressant and mood stabilizing drugs. Journal of Psychiatry and Neuroscience 27, 8–9.
53. Young L.T., Li P.P., Kish S.J., Siu K.P., Kamble A., Hornykiewicz O. et al (1993) Cerebral cortex Gs alpha protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder. Journal of Neurochemistry 61, 890–898.
54. Yuan P.X., Huang L.D., Jiang Y.M., Gutkind J.S., Manji H.K. and Chen G. (2001) The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. Journal of Biological Chemistry 276,31674-31683.
55. Zarate C.A. Jr, Quiroz J.A., Singh J.B., Denicoff K.D., De Jesus G., Luckenbaugh D.A. et al. (2005) An open-label trial of the glutamate modulating agent riluzole in combination with lithium for the treatment of bipolar depression. Biological Psychiatry (in press)
56. Zarate C.A. Jr, Du J., Quiroz J., Gray N.A., Denicoff K.D., Singh J. et al (2003) Regulation of cellular plasticity cascades in the patho-physiology and treatment of mood disorders: role of the glutamatergic system. Annals of the New York Academy of Science 1003, 273–291.
57. Zhu J.J., Qin Y., Zhao M., Van Aelst L. and Malinow R. (2002) Ras and Rap control AMPA receptor trafficking during synaptic plasticity. Cell 110, 443-455